본문으로 바로가기 주메뉴 바로가기

사용자별 맞춤메뉴

자주찾는 메뉴

추가하기
닫기

연구성과

contents area

detail content area

Functional polymorphisms in PD-L1 gene are associated with the prognosis of patients with early stage non-small cell lung cancer
  • 작성일2018-02-14
  • 최종수정일2018-02-14
  • 담당부서연구기획과
  • 연락처043-719-8033
  • 3,290
Gene, 2017, 01, 28─35, DOI: https://doi.org/doi: 10.1016/j.gene.2016.11.007

Functional polymorphisms in PD-L1 gene are associated with the prognosis of patients with early stage non-small cell lung cancer

Shin Yup Lee, Deuk Kju Jung; Jin Eun Choi; Cheng Cheng Jin; Mi Jeong Hong; Sook Kyung Do; Hyo-Gyoung Kang; Won Kee Lee; Yangki Seok; Eung Bae Lee; Ji Yun Jeong; Kyung Min Shin; Seung Soo Yoo; Jaehee Lee; Seung Ick Cha; Chang Ho Kim; Jae Yong Park

Abstract

    Introduction
    This study was conducted to investigate whether polymorphisms of genes involved in immune checkpoints can predict the prognosis of patientswith early stage non-small cell lung cancer (NSCLC) after surgical resection.
    Materials and methods
    Twelve single nucleotide polymorphisms (SNPs) of PD-1, PD-L1, andCTLA-4 geneswere selected and genotyped. A total of 354 patients with early stage NSCLCwho underwent curative surgical resection were enrolled. The association of the SNPs with overall survival (OS) was analyzed.
    Results
    Among the 12 SNPs investigated, PD-L1 rs4143815CNG, rs822336GNC, and rs822337TNA were significantly associated withworse survival outcomes inmultivariate analyses. Whenthe three SNPs were combined,OS decreased in a dose-dependent manner as the number of bad genotypes increased (Ptrend = 0.0003). In the luciferase assay, rs4143815 G allele exhibited a decreased tranion activity compared with C allele (P = 0.001), and the rs822336C-rs822337A haplotype had a decreased promoter activity comparedwith the rs822336G-rs822337T haplotype (P=0.004). Patientswith higher expression of PD-L1 mRNA had a better survival compared with lower expression (P=0.03).
    Conclusions
    PD-L1 polymorphisms may be useful for the prediction of prognosis in patients with surgically resected NSCLC. Further studies are needed to confirm our findings and to understand the role of PD-L1 in the antitumor immunity and prognosis in NSCLC.



  • 본 연구는 질병관리본부 연구개발과제(과제번호 2017-보건의료생물자원종합관리) 연구비를 지원받아 수행되었습니다.
  • This research was supported by a fund(code 2017-보건의료생물자원종합관리) by Research of Korea Centers for Disease Control and Prevention.


본 공공저작물은 공공누리  출처표시+상업적이용금지+변경금지 조건에 따라 이용할 수 있습니다 본 공공저작물은 공공누리 "출처표시+상업적이용금지+변경금지" 조건에 따라 이용할 수 있습니다.
TOP